Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$39,368
in 1 filing

Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing
  2. Nguyen AnhCo −$39K President and CEO sold 5% of stake

Reading 3 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-08-17 Soffer Gad Chief Operating Officer Exercise or conversion · Restricted Stock Units −4,145 40,076
2015-08-17 Soffer Gad Chief Operating Officer Exercise or conversion · Employee Stock Option (Right to Buy) −2,778 37,222
2015-08-17 Clark Mitchall G. Chief R & QA Officer Exercise or conversion +9,615 40,199
2015-08-17 Clark Mitchall G. Chief R & QA Officer Exercise or conversion +1,291 $25.15 $32K 41,490
2015-08-17 Clark Mitchall G. Chief R & QA Officer Exercise or conversion +469 $11.00 $5K 41,959
2015-08-17 Clark Mitchall G. Chief R & QA Officer Sale −7,829 $46.19 $362K 34,130
2015-08-17 Clark Mitchall G. Chief R & QA Officer Exercise or conversion · Restricted Stock Units −9,615 74,519
2015-08-17 Clark Mitchall G. Chief R & QA Officer Exercise or conversion · Employee Stock Option (Right to Buy) −1,291 40,042
2015-08-17 Clark Mitchall G. Chief R & QA Officer Exercise or conversion · Employee Stock Option (Right to Buy) −469 14,531
2015-08-17 Haqq Christopher Chief Medical Officer Exercise or conversion +829 247,494
2015-08-17 Haqq Christopher Chief Medical Officer Sale −1,304 $45.75 $60K 246,190
2015-08-17 Haqq Christopher Chief Medical Officer Sale −300 $46.58 $14K 245,890
2015-08-17 Haqq Christopher Chief Medical Officer Exercise or conversion · Restricted Stock Units −829 8,015
2015-08-17 Ciechanover Isaac E. Chief Executive Officer Exercise or conversion +5,907 41,532
2015-08-17 Ciechanover Isaac E. Chief Executive Officer Exercise or conversion · Restricted Stock Units −5,907 57,108
2015-08-17 Fust Matthew K Director Exercise or conversion +1,603 9,081
2015-08-17 Fust Matthew K Director Exercise or conversion · Restricted Stock Units −1,603 16,559
2015-08-03 Turner Heather D VP, General Counsel & Sec. Grant or award · Employee Stock Option (Right to Buy) +130,000 130,000
2015-07-31 Ciechanover Isaac E. Chief Executive Officer Sale −900 $55.41 $50K 381,882
2015-07-31 Ciechanover Isaac E. Chief Executive Officer Sale −1,100 $56.25 $62K 380,782

Page 63 of 71 · 1,403 trades